CD274 and cancer: The results indicated that IL-17 pathway (hsa04657), NF- κB pathway (hsa04064), HIF-1 pathway (hsa04066), FoxO pathway (hsa04068) and PD-L1-related signaling pathways in cancer (hsa05235) were mainly enriched (Fig. 3A).